These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Targeting glucose-6-phosphate dehydrogenase by 6-AN induces ROS-mediated autophagic cell death in breast cancer. Li Y; Zheng F; Zhang Y; Lin Z; Yang J; Han X; Feng Y; Pei X; Li F; Liu Q; Yan L; Li T; Zhang Y; Li D; Fu Z; Wang C; Sun Q; Li C FEBS J; 2023 Feb; 290(3):763-779. PubMed ID: 36048131 [TBL] [Abstract][Full Text] [Related]
44. Effect of hypoxia on proliferation and glucocorticoid resistance of T-cell acute lymphoblastic leukaemia. Li Y; Wei Y; Gu L Hematology; 2021 Dec; 26(1):775-784. PubMed ID: 34565306 [TBL] [Abstract][Full Text] [Related]
45. EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells. Mariotto E; Bortolozzi R; Volpin I; Carta D; Serafin V; Accordi B; Basso G; Navarro PL; López-Cara LC; Viola G Biochem Pharmacol; 2018 Sep; 155():213-223. PubMed ID: 30006194 [TBL] [Abstract][Full Text] [Related]
46. B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies. Xiao G; Chan LN; Klemm L; Braas D; Chen Z; Geng H; Zhang QC; Aghajanirefah A; Cosgun KN; Sadras T; Lee J; Mirzapoiazova T; Salgia R; Ernst T; Hochhaus A; Jumaa H; Jiang X; Weinstock DM; Graeber TG; Müschen M Cell; 2018 Apr; 173(2):470-484.e18. PubMed ID: 29551267 [TBL] [Abstract][Full Text] [Related]
47. Everolimus shows synergistic antimyeloma effects with bortezomib via the AKT/mTOR pathway. Li J; Liu Z; Li Y; Jing Q; Wang H; Liu H; Chen J; Feng J; Shao Q; Fu R J Investig Med; 2019 Jan; 67(1):39-47. PubMed ID: 29997148 [TBL] [Abstract][Full Text] [Related]
48. NeuroD1 promotes tumor cell proliferation and tumorigenesis by directly activating the pentose phosphate pathway in colorectal carcinoma. Li Z; He Y; Li Y; Li J; Zhao H; Song G; Miyagishi M; Wu S; Kasim V Oncogene; 2021 Dec; 40(50):6736-6747. PubMed ID: 34657129 [TBL] [Abstract][Full Text] [Related]
49. H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth. Lu C; Yang D; Klement JD; Colson YL; Oberlies NH; Pearce CJ; Colby AH; Grinstaff MW; Liu Z; Shi H; Ding HF; Liu K Oncogene; 2022 Apr; 41(18):2651-2662. PubMed ID: 35351997 [TBL] [Abstract][Full Text] [Related]
50. Pyr3, a TRPC3 channel blocker, potentiates dexamethasone sensitivity and apoptosis in acute lymphoblastic leukemia cells by disturbing Ca(2+) signaling, mitochondrial membrane potential changes and reactive oxygen species production. Abdoul-Azize S; Buquet C; Vannier JP; Dubus I Eur J Pharmacol; 2016 Aug; 784():90-8. PubMed ID: 27179991 [TBL] [Abstract][Full Text] [Related]
51. G6PD overexpression protects from oxidative stress and age-related hearing loss. Bermúdez-Muñoz JM; Celaya AM; Hijazo-Pechero S; Wang J; Serrano M; Varela-Nieto I Aging Cell; 2020 Dec; 19(12):e13275. PubMed ID: 33222382 [TBL] [Abstract][Full Text] [Related]
52. Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition. Jing B; Jin J; Xiang R; Liu M; Yang L; Tong Y; Xiao X; Lei H; Liu W; Xu H; Deng J; Zhou L; Wu Y Cell Death Dis; 2018 May; 9(6):589. PubMed ID: 29789603 [TBL] [Abstract][Full Text] [Related]
53. Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. Bonapace L; Bornhauser BC; Schmitz M; Cario G; Ziegler U; Niggli FK; Schäfer BW; Schrappe M; Stanulla M; Bourquin JP J Clin Invest; 2010 Apr; 120(4):1310-23. PubMed ID: 20200450 [TBL] [Abstract][Full Text] [Related]
54. Glucose-6-phosphate dehydrogenase inhibition attenuates acute lung injury through reduction in NADPH oxidase-derived reactive oxygen species. Nadeem A; Al-Harbi NO; Ahmad SF; Ibrahim KE; Siddiqui N; Al-Harbi MM Clin Exp Immunol; 2018 Mar; 191(3):279-287. PubMed ID: 29277898 [TBL] [Abstract][Full Text] [Related]
55. Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK. Liu Y; Ge J; Li Q; Guo X; Gu L; Ma ZG; Li XH; Zhu YP Leuk Lymphoma; 2014 Sep; 55(9):2179-88. PubMed ID: 24597985 [TBL] [Abstract][Full Text] [Related]
56. Inhibition of mammalian target of rapamycin signaling by everolimus induces senescence in adult T-cell leukemia/lymphoma and apoptosis in peripheral T-cell lymphomas. Darwiche N; Sinjab A; Abou-Lteif G; Chedid MB; Hermine O; Dbaibo G; Bazarbachi A Int J Cancer; 2011 Aug; 129(4):993-1004. PubMed ID: 21064094 [TBL] [Abstract][Full Text] [Related]
57. RHEB is a potential therapeutic target in T cell acute lymphoblastic leukemia. Pham LT; Peng H; Ueno M; Kohno S; Kasada A; Hosomichi K; Sato T; Kurayoshi K; Kobayashi M; Tadokoro Y; Kasahara A; Shoulkamy MI; Xiao B; Worley PF; Takahashi C; Tajima A; Hirao A Biochem Biophys Res Commun; 2022 Sep; 621():74-79. PubMed ID: 35810594 [TBL] [Abstract][Full Text] [Related]
58. Combined Use of Metformin and Everolimus Is Synergistic in the Treatment of Breast Cancer Cells. Wang Y; Wei J; Li L; Fan C; Sun Y Oncol Res; 2014; 22(4):193-201. PubMed ID: 26351208 [TBL] [Abstract][Full Text] [Related]